Abstract
to have recurrence either local or metastatic. Initial data were obtained for 85 women. Treatment data: There was a significant relationship between the average baseline scores and patient age (P 50:037) for the vagina scale score and also for sexual dysfunction (P 50:038). There was no significant relationship for vagina scores and stage of disease (P 5 0:054) or for sexual dysfunction and stage P 50:44. There was a significant relationship between the maximum vagina scores at baseline and age (P 50:039), but not for stage of disease (P 5 0:077). For sexual dysfunction maximum scores there was no significant association with age (P 50:095) or disease stage. (P 50:31). Nineteen of the 85 patients had prior treatment with surgery and both their average vagina scores (P 50:025) and maximum vagina (P 50:045) scoreswere significantly lower than those for non-surgically treated patients. Similarly for sexual dysfunction scores,the averages scores (P 50:042) for those patients who had prior surgery were lower than those who had no surgery and the maximum score was significantly different (P 50:027). Statistical analysis of data: The mean subjective sexual function and satisfaction score was highest (0.4601) in patients in which gap between treatment and interview was 11 years and maximum score was highest (0.94) in same group. Average subjective LENT SOMA score was highest in patients who were interviewed after 11 years of treatment in comparison to other patients. The objective mean score VG (Vagina) was highest (0.6444) in patients who were interviewed after 11 years of treatment and maximum score (0.80) was highest (0.80) in patients in which gap between treatment and interview was 10 years. Average objective LENT SOMA score was highest in patients who were interviewed after 11 years of treatment in comparison to other patients (p value0.693). Average overall LENT SOMA score was highest in patients in which gap between treatment and interview was 11 years. (p value0.705) Conclusions: The LENT SOMA system was acceptable and feasible to use and gave us an insight into the morbidity in our patients. Since it is one of few studies in India on late morbidity in treated patients of carcinoma uterine cervix, it is an important step in comparing our data with the Western literature. It will also help us to develop effective management plans to reduce the post treatment symptoms and improve quality of life in patients of carcinoma uterine cervix.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call